Skip to main content
. 2016 Aug 11;6:29540. doi: 10.1038/srep29540

Figure 2. Clinical effect of combined Ganoderma lucidum against the smallest worthwhile clinical effect for HbA1c (panel A, upper) and FPG (panel B, lower).

Figure 2